Cerity Partners LLC Sage Therapeutics, Inc. Transaction History
Cerity Partners LLC
- $48.7 Billion
- Q1 2025
A detailed history of Cerity Partners LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 50,042 shares of SAGE stock, worth $358,801. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,042Holding current value
$358,801% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SAGE
# of Institutions
195Shares Held
45.3MCall Options Held
304KPut Options Held
117K-
Black Rock Inc. New York, NY5.22MShares$37.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$36.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.59MShares$32.9 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.46MShares$32 Million0.48% of portfolio
-
Rtw Investments, LP New York, NY3MShares$21.5 Million0.27% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $426M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...